GlassScriptPhysician profile
Cameo Ashley Carter
NPI 1447458963
$1,533.68
in general payments reported to CMS, 2019-2025
17 companies · $200 in 2025
The $200 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $175 · 2020: $68.91 · 2021: $225 · 2022: $345 · 2023: $276 · 2024: $245 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $354.12 | 2021-2024 | Jornay Pm |
| Pfizer INC. | $216.49 | 2019-2025 | |
| Corium, LLC | $164.66 | 2023-2025 | Azstarys |
| Merck Sharp & Dohme LLC | $128.50 | 2019-2024 | M-M-R II, Gardasil 9, Vaxelis |
| Sanofi Pasteur INC. | $111.79 | 2019-2025 | |
| Supernus Pharmaceuticals, INC. | $102.94 | 2021-2023 | Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $84.79 | 2020-2022 | |
| Sobi, INC | $84.03 | 2019-2023 | |
| Glaxosmithkline, LLC. | $66.37 | 2020-2021 | |
| Seqirus USA INC | $58.19 | 2021-2023 | Flucelvax Quadrivalent |
| Cranial Technologies, INC | $33.35 | 2019-2025 | Doc Band |
| Alk-Abello, INC | $28.25 | 2025 | Neffy |
| Dermira, INC. | $23.95 | 2019 | |
| Phadia US INC. | $20.95 | 2024 | Immunocap |
| Ars Pharmaceuticals Operations, INC. | $20.95 | 2025 | Neffy |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lnhc, INC | $18.86 | 2025 | Zelsuvmi |
| Collegium Pharmaceutical, INC. | $15.49 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameo Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.